Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

Stopped Study halted prior to enrollment of first participant. (It has been determined on 2018 May 15 that the NCT03275558 study will be stopped by sponsor decision)

Conditions

• Recurrent Glioblastoma
• Gliosarcoma
• Anaplastic Gliomas

Interventions

• DRUG: Axitinib 1 MG
• DRUG: Sunitinib 5 MG
• DRUG: Pazopanib 5 MG

Sponsor

Center Trials & Treatment